Assertio Holdings Overview

  • Year Founded
  • 1995

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 60

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $101M

Assertio Holdings General Information

Description

Assertio Holdings Inc is a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients' needs. The group's focus is on supporting patients by marketing oncology, neurology, and pain management products.

Contact Information

Formerly Known As
Depomed
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 100 South Saunders Road
  • Suite 300
  • Lake Forest, IL 60045
  • United States
+1 (224)
Primary Industry
Pharmaceuticals
Parent Company
Vertical(s)
Corporate Office
  • 100 South Saunders Road
  • Suite 300
  • Lake Forest, IL 60045
  • United States
+1 (224)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Assertio Holdings Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
17. Merger/Acquisition 16-Jun-2026 $101M Completed Generating Revenue
16. PIPE 12-Feb-2021 Completed Generating Revenue
15. PIPE 09-Feb-2021 Completed Generating Revenue
14. Debt Refinancing 13-Aug-2017 Cancelled Profitable
13. Buyout/LBO Cancelled Profitable
12. Debt Repayment 04-Apr-2016 Completed Profitable
11. Merger/Acquisition 19-Nov-2015 Cancelled Profitable
10. Debt - Acquisition 12-Mar-2015 Completed Profitable
9. Secondary Transaction - Private 01-Jan-2006 $61.3M Completed Generating Revenue
8. PIPE 22-Apr-2003 $20M $61.3M Completed Generating Revenue
To view Assertio Holdings’s complete valuation and funding history, request access »

Assertio Holdings Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Assertio Holdings Inc is a pharmaceutical company with comprehensive commercial capabilities offering differentiated pro
Pharmaceuticals
Lake Forest, IL
60 As of 2026

Kilmeaden, Ireland
 

Vienna, Austria
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Assertio Holdings Competitors (26)

One of Assertio Holdings’s 26 competitors is Genzyme Ireland, a Corporation company based in Kilmeaden, Ireland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genzyme Ireland Corporation Kilmeaden, Ireland
Pfizer (Vienna) Corporation Vienna, Austria
Pfizer Pakistan Corporation Karachi, Pakistan
Grifols Corporation Barcelona, Spain
Johnson&Johnson Innovative Medicine Venture Capital-Backed Raritan, NJ
You’re viewing 5 of 26 competitors. Get the full list »

Assertio Holdings Patents

Assertio Holdings Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2016100564-A1 Liquid dispensing device with electronic counting component Inactive 16-Dec-2014
US-20140066411-A1 Pharmaceutical compositions for extended release of azo-bonded 5-aminosalicylic acid compositions Inactive 28-Aug-2012
US-20130316002-A1 Compositions and methods for treating gastrointestinal motility dysfunction Inactive 22-May-2012
CA-2850468-A1 Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract Active 28-Sep-2010
CA-2850468-C Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract Inactive 28-Sep-2010 A61K9/0065
To view Assertio Holdings’s complete patent history, request access »

Assertio Holdings Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Assertio Holdings Former Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Biovail Corporation Minority
CSO Ventures Corporation Minority
Cygnus Therapeutics Systems Other Minority
Deerfield Management Venture Capital Minority
Easton Capital Investment Group Venture Capital Minority
You’re viewing 5 of 13 investors. Get the full list »

Assertio Holdings Investments & Acquisitions (10)

Assertio Holdings’s most recent deal was a Merger/Acquisition with Spectrum Pharmaceuticals for . The deal was made on 31-Jul-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Spectrum Pharmaceuticals 31-Jul-2023 Merger/Acquisition Drug Discovery
Sympazan 27-Oct-2022 Merger/Acquisition Pharmaceuticals
Antares Pharma (Otrexup Injection Treatment Medicine) 15-Dec-2021 Corporate Asset Purchase Buildings and Property
Zyla Life Sciences 20-May-2020 Merger/Acquisition Drug Delivery
Slán Medicinal Holdings (Cosyntropin Depot) 07-Nov-2017 Corporate Asset Purchase Buildings and Property
You’re viewing 5 of 10 investments and acquisitions. Get the full list »

Assertio Holdings ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

39.12 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,593

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Pharmaceuticals

Subindustry

of 354

Rank

Percentile

To view Assertio Holdings’s complete esg history, request access »

Assertio Holdings Affiliates

Subsidiaries (5)

Name Industry Location Year Founded
Antares Pharma (Otrexup Injection Treatment Medicine) Ewing, NJ 2014
Spectrum Pharmaceuticals Boston, MA 1987
Assertio Distribution Lake Forest, IL
Assertio Management Lake Forest, IL
Depo Dr Sub Lake Forest, IL

Assertio Holdings FAQs

  • When was Assertio Holdings founded?

    Assertio Holdings was founded in 1995.

  • Where is Assertio Holdings headquartered?

    Assertio Holdings is headquartered in Lake Forest, IL.

  • What is the size of Assertio Holdings?

    Assertio Holdings has 60 total employees.

  • What industry is Assertio Holdings in?

    Assertio Holdings’s primary industry is Pharmaceuticals.

  • Is Assertio Holdings a private or public company?

    Assertio Holdings is a Private company.

  • What is the current valuation of Assertio Holdings?

    The current valuation of Assertio Holdings is .

  • What is Assertio Holdings’s current revenue?

    The current revenue for Assertio Holdings is .

  • How much funding has Assertio Holdings raised over time?

    Assertio Holdings has raised $685M.

  • Who are Assertio Holdings’s investors?

    Biovail, CSO Ventures, Cygnus Therapeutics Systems, Deerfield Management, and Easton Capital Investment Group are 5 of 13 investors who have invested in Assertio Holdings.

  • Who are Assertio Holdings’s competitors?

    Genzyme Ireland, Pfizer (Vienna), Pfizer Pakistan, Grifols, and Johnson&Johnson Innovative Medicine are some of the 26 competitors of Assertio Holdings.

  • When was Assertio Holdings acquired?

    Assertio Holdings was acquired on 16-Jun-2026.

  • Who acquired Assertio Holdings?

    Assertio Holdings was acquired by Zydus Lifesciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process